Another example of the crosstalk between c-MYC and growth factors are double transgenic mice expressing epidermal growth factor (EGF) and c-MYC, in which exacerbated tumor progression and mortality led to the occurrence of HCC in 100% of the mice after approximately 12–18 weeks [36,37]. This evidence concerns the gene EGF and hepatocellular carcinoma.